Effect of Preemptive Epidural Analgesia in Labor on Cytokine Production

Status Completed

Clinical Trial Summary

During labor there is an increased production of inflammatory mediators called cytokines. Higher concentration of certain cytokines has been linked to adverse neonatal and maternal outcomes.

Epidural analgesia is commonly performed after the parturient feels labor pain.

We hypothesis that preemptive epidural analgesia (initiated before labor pain begins)can influence the production of cytokines.

Clinical Trial Description

The interrelationship between vaginal labor, cytokine production, and epidural analgesia is unknown. Vaginal delivery is thought to induce a maternal inflammatory response. Though epidural analgesia during labor was found to significantly influence peripartum maternal and newborn interleukin concentrations, these studies did not address at what stage epidural analgesia was performed. Preemptive analgesia has been found to be associated with attenuated proinflammatory cytokines, at least in the postoperative period.

Healthy ASA I term parturients (>37 weeks) being accepted into delivery ward and wanting epidural analgesia will be studied.

Parturients will be divided into two groups:

- Group I- those who have painless contractions awaiting augmentation of labor.

- Group II- parturients with cervical dilatation and painful labor (VAS >5).

Parturients in Group I will be given epidural analgesia immediately upon arrival in the labor ward before onset of painful contractions (VAS<3). Parturients in Group 2 will be given epidural analgesia as soon as possible.

Epidural analgesia protocol will be identical for both groups: graduated doses of bupivicaine 0.1% 15cc and 100 mcg fentanyl followed by patient controlled analgesia at a concentration of bupivicaine 0.1% and fentanyl 2 mcg/cc delivered at 10cc per hour with possible boluses of 5 cc every ten minutes.

Maternal serum will be drawn before epidural insertion and 18-24 hours after delivery. Placental blood will be drawn after delivery.

These blood sample will be assessed for IL-1Beta, TNF alpha, IL-1ra, IL-2, Il-6, IL-8, IL-10, IL-18.

The patient's chart will be prospectively analyzed for demographic information about parturient and complications and progress of labor. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00361712
Study type	Interventional
Source	Rabin Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	July 2006
Completion date	July 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04037085` - Ketamine to Improve Recovery After Cesarean Delivery - Part 1	Phase 2
Recruiting	`NCT03623256` - Comparison of Intrathecal Versus Epidural Fentanyl on Fetal Bradycardia in Labor Combined Spinal Epidural Analgesia	Phase 4
Completed	`NCT04443569` - Lidocaine Patches After Cesarean Section	Phase 3
Completed	`NCT03502642` - Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery	Phase 4
Completed	`NCT03596333` - Color Doppler Ultrasound to Locate Needle in Labor Epidural
Recruiting	`NCT02427139` - ANSiStim Study for Active Labor Pain	N/A
Not yet recruiting	`NCT06304246` - The Relationship Between Preoperative Serum Asprosin Level and Postoperative Analgesic Consumption in Patients Undergoing Caesarean Section
Completed	`NCT06429111` - Effectiveness and Safety in Maternal and Neonatal Outcomes in Water Birth.
Not yet recruiting	`NCT05196256` - Study Comparing Dural Puncture Epidural With Epidural and Combined Spinal Epidural Anesthesia for Obstetric Analgesia.	Phase 3
Not yet recruiting	`NCT04983511` - Electrical Epidural Stimulation Test for Detecting Epidural Catheter Reactivation in Obstetric Population	N/A
Completed	`NCT02244086` - Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in Labor	Phase 4
Completed	`NCT03495531` - Virtual Reality in Obstetric Patients	N/A
Completed	`NCT03634111` - The Effect of the Transversus Abdominis Plane Block to Postoperative Analgesia for Cesarean Section	N/A
Terminated	`NCT04011098` - Improving Labour Induction Analgesia: Epidural Fentanyl Bolus at Epidural Initiation for Induction of Labour	Phase 1
Not yet recruiting	`NCT06055686` - The Use of Electrical Stimulation for Determination of Epidural Catheter Placement	N/A
Withdrawn	`NCT02857465` - Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome	Phase 3
Completed	`NCT02340806` - Association Between Bolus Rate and the Adequacy of Labor Analgesia Using Timed-intermittent Boluses	N/A
Recruiting	`NCT04728048` - Dural Puncture Epidural VS Standard Epidural on Physician Top-ups During Labour Analgesia	N/A
Completed	`NCT05447455` - TAP Block vs LAWI for Analgesia Post-cesarean Section	N/A
Completed	`NCT04637386` - TAP Block vs LAWI for Analgesia Post-cesarean Section: RCT	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.